Skip to main content
Ted Dawson, MD, Neurology, Baltimore, MD

TedMurrayDawsonMD

Neurology • Baltimore, MD

Professor of Neurology, Professor of Neuroscience, Professor of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine; Director, Institute for Cell Engineering, Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases

Join to view full profile

Dr. Dawson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Dawson's full profile

Already have an account?

  • Office

    600 N Wolfe St
    Baltimore, MD 21287
    Phone+1 410-955-9441

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Neurology, 1987 - 1990
  • University of Utah Health
    University of Utah HealthInternship, Internal Medicine, 1986 - 1987
  • University of Utah School of Medicine
    University of Utah School of MedicineClass of 1986

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1990 - 2026
  • PA State Medical License
    PA State Medical License 1988 - 1990
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Poly(ADP-Ribose) Drives Pathologic Α-synuclein Neurodegeneration in Parkinson’s Disease  
    James B Leverenz, Ted M Dawson, Alexander Pantelyat, Liana S Rosenthal, Juan C Troncoso, Science Magazine
  • A Comprehensive Screening of Copy Number Variability in Dementia with Lewy Bodies  
    Eliezer Masliah, Ted Dawson, Nigel J Cairns, John C Morris, Sonja W Scholz, John Q Trojanowski, Liana Rosenthal, Lawrence S Honig, Douglas Galasko, Thomas G Beach, Ron..., ScienceDirect
  • Block of A1 Astrocyte Conversion by Microglia Is Neuroprotective in Models of Parkinson’s Disease  
    Zoltan Mari, Ted M Dawson, Nature

Press Mentions

  • New Study Suggests Cancer Drug Could Be Used to Target Protein Connection That Spurs Parkinson’s Disease
    New Study Suggests Cancer Drug Could Be Used to Target Protein Connection That Spurs Parkinson’s DiseaseJune 17th, 2024
  • After Weight Loss, Alzheimer’s May Be Next Frontier for Drugs like Ozempic
    After Weight Loss, Alzheimer’s May Be Next Frontier for Drugs like OzempicMay 8th, 2023
  • After Weight Loss, Alzheimer’s May Be Next Frontier for Drugs like Ozempic
    After Weight Loss, Alzheimer’s May Be Next Frontier for Drugs like OzempicMay 8th, 2023
  • Join now to see all

Grant Support

  • MIF Nuclease actions in Synuclein DementiasJOHNS HOPKINS UNIVERSITY2023–2028
  • Parthanatos, PAAN/MIF nuclease Activation in Ischemic InjuryJOHNS HOPKINS UNIVERSITY2010–2028
  • The Morris K Udall Parkinson'S Disease Research Center Of ExcellenceNational Institute Of Neurological Disorders And Stroke2009–2011
  • Biology Of Parkin And Its Role In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2009–2011
  • Administrative CoreNational Institute Of Neurological Disorders And Stroke2009–2011
  • Understanding NO Signaling Resulting In Neuroprotection.National Institute On Drug Abuse2007–2011
  • Transgenic And Neurobehavior CoreNational Institute Of Neurological Disorders And Stroke2004–2011
  • The Role Of Parkin In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2004–2009
  • Parkinson'S Disease Research Center Of ExcellenceNational Institute Of Neurological Disorders And Stroke2004–2009
  • Poly (Adp-Ribose) Signalling In Glutamate ExcitotoxicityNational Institute Of Neurological Disorders And Stroke2004–2008
  • Mouse Models Of Parkin Biology And PathobiologyNational Institute Of Neurological Disorders And Stroke2004–2008
  • Jhmi Clinical Center For Parkinson'S Disease Neuroprotection TrialsNational Institute Of Neurological Disorders And Stroke2007
  • Reversible And Temporally Inducible LRRK2 Knockout MiceNational Institute Of Neurological Disorders And Stroke2006–2007
  • Models Of Familial Parkinson'S Disease: PINK1National Institute Of Neurological Disorders And Stroke2005–2006
  • Jhmi Clinical Center For PD Neuroprotection TrialsNational Institute Of Neurological Disorders And Stroke2002–2006
  • Models Of Familial Parkinson'S Disease: DJ-1 KnockoutsNational Institute Of Neurological Disorders And Stroke2004–2005
  • Administrative &Training CoreNational Institute Of Neurological Disorders And Stroke2004
  • Apoptosis Inducing Factor In Dopaminergic Cell DeathNational Institute Of Neurological Disorders And Stroke2002–2003
  • Parkinsons Disease Research Center Of ExcellenceNational Institute Of Neurological Disorders And Stroke1998–2003
  • Excitotoxins And PARP In Striatal VulnerabilityNational Institute Of Neurological Disorders And Stroke1999–2002
  • Core--Gene TransferNational Institute Of Neurological Disorders And Stroke1999–2002
  • Molecular Mechanisms Of MPTP NeurotoxicityNational Institute Of Neurological Disorders And Stroke1998–2002
  • Core--Transgenic And Neurobehavior FacilityNational Institute Of Neurological Disorders And Stroke1998–2002
  • Transcriptional Regulation In Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1997–2001
  • Glutamate Neurotoxicity In Neuronal NOS KnockoutsNational Institute Of Neurological Disorders And Stroke1995–1998
  • Nitric Oxide As A Mediator Of NeurotoxicityNational Institute Of Neurological Disorders And Stroke1992–1996

Professional Memberships

External Links

Dr. Ted Dawson, Dr. Ted Dawson, MD, Dr. T Dawson, Dr. Ted Murray Dawson